<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04118634</url>
  </required_header>
  <id_info>
    <org_study_id>PE2019</org_study_id>
    <nct_id>NCT04118634</nct_id>
  </id_info>
  <brief_title>A Regietry Study on Biomarkers of Pulmonary Embolism</brief_title>
  <acronym>BIO-PE</acronym>
  <official_title>Evaluation of Performances of Biomarkers in Pulmonary Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Institute of Heart, Lung and Blood Vessel Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Institute of Heart, Lung and Blood Vessel Diseases</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the value of biomarkers in the diagnosis and risk
      stratification of patients with suspected pulmonary embolism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Management of patients with acute pulmonary embolism is a serious problem. The rapid and
      accurate diagnosis and risk stratification of these patients is an important unmet clinical
      need. The aim of the study is to evaluate the value of biomarkers, alone or in combination,
      in the diagnosis and risk stratification of patients with suspected pulmonary embolism
      presenting to the emergency department.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 18, 2015</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the ROC curve of biomarkers for the diagnosis of PE</measure>
    <time_frame>2 years</time_frame>
    <description>The ROC curve will be built, the area under the curve will be calculated with its confidence interval.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PE related death</measure>
    <time_frame>7 days</time_frame>
    <description>Number of PE related death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptomatic recurrent venous thromboembolic events</measure>
    <time_frame>2 years</time_frame>
    <description>Number of symptomatic recurrent venous thromboembolic event</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">480</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Group with PE</arm_group_label>
    <description>The criteria for confirmation of PE are:
PE on spiral computed tomography (CT) proximal deep vein thrombosis on ultrasound (US) thromboembolic events objectively confirmed during the follow up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group without PE</arm_group_label>
    <description>The criteria for exclusion of PE are:
low or moderate clinical probability and D-dimer ELISA &lt;0.50 µg/mL or &lt;10xage in patients older than 50 years and negative follow up low and moderate clinical probability and negative CT and negative follow up high clinical probability and negative CT, US and follow up.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to the emergency department with suspected PE
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged ≥ 18 years that presents to an emergency department

          -  With suspected PE defined as new onset of or worsening of shortness of breath or chest
             pain

        Exclusion Criteria:

          -  Hemodynamic instability

          -  Life expectancy less than 3 months

          -  First symptoms 15 day or more before inclusion

          -  Inability to the follow-up visits

          -  Therapeutic anticoagulation for any indication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jie Du, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Anzhen Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yulin Li, PhD</last_name>
    <phone>0086-010-64456453</phone>
    <email>lyllyl_1111@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yulin Li, PhD</last_name>
      <email>lyllyl_1111@163.com</email>
    </contact>
    <investigator>
      <last_name>Jie Du, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>October 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2019</study_first_posted>
  <last_update_submitted>October 4, 2019</last_update_submitted>
  <last_update_submitted_qc>October 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

